Back for its 24th Annual Edition, this global bio-pharma industry event will address the main challenges in investment for 2024 as well as partnering and alliance management and prospects for 2025. Key players will contribute their insights in panels, which will cover the macro picture as well as innovation in different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.